MYBPC3无义突变通过慢性激活无义介导衰变导致肥厚型心肌病
本研究利用基因组编辑构建携带MYBPC3无义突变(p.R943x;p.R1073P_Fsx4)的等基因诱导多能干细胞来源心肌细胞(iPSC-CMs),发现突变细胞钙处理异常(衰减动力学延长、舒张期钙升高)但无结构或收缩异常,MYBPC3 mRNA显著降低而蛋白水平相当,无截短肽,无义介导衰变通路激活且心脏信号通路基因失调,抑制该通路可逆转分子表型和钙异常。结论提示慢性激活的无义介导衰变通路与HCM发病直接相关。
要点
- MYBPC3无义突变iPSC-CMs出现钙处理异常但无结构或收缩功能障碍。
- 突变细胞MYBPC3 mRNA降低但蛋白水平相当,未检测到截短肽,不支持单倍剂量不足。
- 抑制无义介导衰变通路可逆转分子表型和钙处理异常。
核心结论
- 携带MYBPC3无义突变的iPSC-CMs在无显著MYBPC3蛋白单倍剂量不足的情况下出现钙信号异常和分子失调。
- 首次提供慢性激活的无义介导衰变通路与HCM疾病发展直接相关的证据。
研究设计与样本
- 利用基因组编辑从携带MYBPC3无义突变(p.R943x;p.R1073P_Fsx4)的HCM患者生成等基因iPSC细胞系。
- 在iPSC-CMs中进行全面的表型和转录组分析。
主要发现
- HCM iPSC-CMs与等基因对照相比,钙处理特性异常,衰减动力学延长,舒张期钙水平升高,但无结构异常或收缩功能障碍。
- 突变iPSC-CMs中MYBPC3 mRNA表达水平显著降低,但等基因iPSC-CMs间蛋白水平相当,未检测到截短MYBPC3肽。
- 无义介导衰变通路激活,参与主要心脏信号通路的基因集失调,提示体外HCM基因特征。
- 在突变iPSC-CMs中特异性抑制无义介导衰变通路可逆转分子表型并使钙处理异常正常化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is frequently caused by mutations in myosin-binding protein C3 ( MYBPC3) resulting in a premature termination codon (PTC). The underlying mechanisms of how PTC mutations in MYBPC3 lead to the onset and progression of HCM are poorly understood. This study's aim was to investigate the molecular mechanisms underlying the pathogenesis of HCM associated with MYBPC3 PTC mutations by utilizing human isogenic induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). METHODS: Isogenic iPSC lines were generated from HCM patients harboring MYBPC3 PTC mutations (p.R943x; p.R1073P_Fsx4) using genome editing. Comprehensive phenotypic and transcriptome analyses were performed in the iPSC-CMs. RESULTS: We observed aberrant calcium handling properties with prolonged decay kinetics and elevated diastolic calcium levels in the absence of structural abnormalities or contracile dysfunction in HCM iPSC-CMs as compared to isogenic controls. The mRNA expression levels of MYBPC3 were significantly reduced in mutant iPSC-CMs, but the protein levels were comparable among isogenic iPSC-CMs, suggesting that haploinsufficiency of MYBPC3 does not contribute to the pathogenesis of HCM in vitro. Furthermore, truncated MYBPC3 peptides were not detected. At the molecular level, the nonsense-mediated decay pathway was activated, and a set of genes involved in major cardiac signaling pathways was dysregulated in HCM iPSC-CMs, indicating an HCM gene signature in vitro. Specific inhibition of the nonsense-mediated decay pathway in mutant iPSC-CMs resulted in reversal of the molecular phenotype and normalization of calcium-handling abnormalities. CONCLUSIONS: iPSC-CMs carrying MYBPC3 PTC mutations displayed aberrant calcium signaling and molecular dysregulations in the absence of significant haploinsufficiency of MYBPC3 protein. Here we provided the first evidence of the direct connection between the chronically activated nonsense-mediated decay pathway and HCM disease development.
引用
- Seeger T, Shrestha R, Lam CK, et al. A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay. Circulation. 2019. PMID: 30586709. doi:10.1161/CIRCULATIONAHA.118.034624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。